Altimmune Inc (NAS:ALT)
$ 8.85 0.28 (3.27%) Market Cap: 629.45 Mil Enterprise Value: 471.93 Mil PE Ratio: 0 PB Ratio: 4.71 GF Score: 30/100

Q3 2020 Altimmune Inc Earnings Call Transcript

Nov 10, 2020 / 01:30PM GMT
Release Date Price: $9.33 (+19.08%)
Operator

Good morning, and welcome to the Altimmune Inc. Third Quarter 2020 Earnings Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Stacey Jurchison. Please go ahead.

Stacey Jurchison

Thank you, operator, and thank you, everyone, for participating in Altimmune's Third Quarter 2020 Earnings Conference Call. Leading the call today will be Vipin Garg, Chief Executive Officer of Altimmune. Other members of the Altimmune executive team participating on the call today are Will Brown, Chief Financial Officer; Scot Roberts, Chief Scientific Officer; and Scott Harris, Chief Medical Officer.

After the prepared remarks, we will hold a question-and-answer session. A press release with our third quarter 2020 financial results was issued last night and can be found on the IR section of our website.

Before we begin, I'd like to remind everyone that remarks about future expectations, plans and prospects constitute forward-looking statements for purposes of Safe Harbor provisions

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot